Zoetermeer Study: double-blind randomised, placebo-controlled clinical study to investigate the effects of daily oral atamestane (100 mg/day) and dehydroepiandrosterone (50 mg/day) alone and in a combined regimen on physical frailty and quality of life in 100 elderly male volunteers over a treatment period of 36 weeks.
Phase of Trial: Phase IV
Latest Information Update: 04 Feb 2009
At a glance
- Drugs Atamestane; Prasterone
- Indications Musculoskeletal disorders
- Focus Pharmacodynamics
- 04 Feb 2009 New trial record